Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Safety and Early Efficacy Trial of Hydroxychloroquine as Primary Prevention of Corona Virus Disease 2019 in High Risk Health Care Providers

NCT04345653 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.

NCT NCT04345653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04345653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Safety and Early Efficacy Trial of Hydroxychloroquine as Primary Prevention of Corona Virus Disease 2019 in High Risk Health Care Providers
Lead sponsor
Hackensack Meridian Health
Phase
Phase 2
Overall status
Completed
Start date
April 14, 2020
Completion date
May 10, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19